30th Jul 2020 17:03
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. |
Company dealt in | WILLIS TOWERS WATSON PLC |
Class of relevant security to which the dealings being disclosed relate (Note 2) | ORD |
Date of dealing | 29 JULY 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,516,248 | 1.18% | 465,202 | 0.36% | ||
(2) | Derivatives (other than options): | ||||
355,000 | 0.28% | 383,659 | 0.30% | ||
(3) | Options and agreements to | ||||
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
(4) | TOTAL: | ||||
1,871,248 | 1.45% | 848,861 | 0.66% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 3 | 210.7200 USD |
| Purchase | 50 | 210.1600 USD |
| Purchase | 100 | 210.3600 USD |
| Purchase | 100 | 210.0100 USD |
| Purchase | 100 | 210.3200 USD |
| Purchase | 100 | 210.4750 USD |
| Purchase | 100 | 210.0400 USD |
| Purchase | 200 | 209.7477 USD |
| Purchase | 200 | 210.2000 USD |
| Purchase | 421 | 210.5673 USD |
| Purchase | 500 | 210.4280 USD |
| Purchase | 669 | 210.3989 USD |
| Purchase | 800 | 210.3025 USD |
| Purchase | 993 | 209.5675 USD |
| Purchase | 1,000 | 210.3090 USD |
| Purchase | 1,100 | 209.7004 USD |
| Purchase | 1,700 | 209.9250 USD |
| Purchase | 2,328 | 210.1311 USD |
| Purchase | 6,102 | 210.1300 USD |
| Purchase | 6,743 | 210.2937 USD |
| Purchase | 22,956 | 210.2732 USD |
| Sale | 1 | 210.7800 USD |
| Sale | 2 | 210.6900 USD |
| Sale | 8 | 209.6200 USD |
| Sale | 148 | 210.3695 USD |
| Sale | 176 | 210.2542 USD |
| Sale | 190 | 210.4220 USD |
| Sale | 190 | 210.2500 USD |
| Sale | 250 | 210.2764 USD |
| Sale | 342 | 210.2605 USD |
| Sale | 366 | 210.3122 USD |
| Sale | 429 | 210.4600 USD |
| Sale | 494 | 210.3496 USD |
| Sale | 779 | 210.5039 USD |
| Sale | 800 | 210.3025 USD |
| Sale | 948 | 210.2810 USD |
| Sale | 968 | 210.4429 USD |
| Sale | 992 | 209.6885 USD |
| Sale | 1,100 | 209.7004 USD |
| Sale | 1,409 | 209.9196 USD |
| Sale | 2,636 | 210.1535 USD |
| Sale | 4,778 | 210.1856 USD |
| Sale | 6,102 | 210.1300 USD |
| Sale | 23,157 | 210.2731 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) YES/NO
Date of disclosure | 30 JULY 2020 |
Contact name | Large Holdings Regulatory Operations |
Telephone number | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection (Note 10) |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20200730005785/en/
Copyright Business Wire 2020
Related Shares:
Barclays